Acarbose
Also known as: Precose
Classification
Pharmaceutical
Regulatory Status
FDA-approved prescription product or labeled drug class
Mechanism Summary
Acarbose is represented by its commonly described alpha-glucosidase inhibitor mechanism. This conservative launch record supports search and overlap detection, not medical recommendation.
Pathways
carbohydrate-absorptionglucose-regulationalpha-glucosidase inhibitorpostprandial-glucose-control
Benefits
Evidence reviewed for type 2 diabetes per product label; BioStack presents this as educational reference, not a recommendation.
Drug Interactions
digestive enzyme products — Potential additive or opposing effects may occur. (review)
References
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Acarbose
Educational reference only — not medical advice.